HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hemolysis of human red blood cells by riboflavin-Cu(II) system.

Abstract
The photodynamic action of riboflavin is generally considered to involve the generation of reactive oxygen species, whose production is enhanced when Cu(II) is present in the reaction. In the present study we report that photoactivated riboflavin causes K(+) loss from fresh human red blood cells (RBC) in a time dependent manner. Addition of Cu(II) further enhances the K(+) loss and also leads to significant hemolysis. Riboflavin in a 2:1 stoichiometry with Cu(II) leads to maximum K(+) loss and up to 45% hemolysis. Bathocuproine, a specific Cu(I)-sequestering agent, when present in the reaction, inhibits the hemolysis completely. Free radical scavengers like superoxide dismutase, potassium iodide and mannitol inhibited the hemolysis up to 55% or more. However, thiourea was the most effective scavenger showing 90% inhibition. These results suggest that K(+) leakage and hemolysis of human RBC are basically free radical mediated reactions.
AuthorsI Ali, M K Gatasheh, I Naseem
JournalBiochimica et biophysica acta (Biochim Biophys Acta) Vol. 1523 Issue 2-3 Pg. 225-9 (Oct 18 2000) ISSN: 0006-3002 [Print] Netherlands
PMID11042388 (Publication Type: Journal Article)
Chemical References
  • Free Radical Scavengers
  • Phenanthrolines
  • Copper
  • bathocuproine
  • Potassium
  • cupric chloride
  • Riboflavin
Topics
  • Copper (pharmacology)
  • Erythrocytes (drug effects, physiology)
  • Free Radical Scavengers (pharmacology)
  • Hemolysis (drug effects)
  • Humans
  • In Vitro Techniques
  • Kinetics
  • Phenanthrolines (pharmacology)
  • Potassium (blood)
  • Riboflavin (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: